Mark W Hahn insider trades: Verona Pharma (VRNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | VRNA | ↓ Sell | 208,912 | $13.14 | $2.7M | Direct | Aug 5, 2025 (4d) |
| Jun 11, 2025 | VRNA | ↓ Sell | 400,000 | $11.40 | $4.6M | Direct | Jun 13, 2025 (2d) |
| May 29, 2025 | VRNA | ↓ Sell | 400,000 | $9.33 | $3.7M | Direct | May 29, 2025 (0d) |
| May 2, 2025 | VRNA | ↓ Sell | 587,008 | $9.05 | $5.3M | Direct | May 5, 2025 (3d) |
| Apr 29, 2025 | VRNA | ↓ Sell | 90,360 | $8.98 | $811K | Direct | May 1, 2025 (2d) |
| Dec 6, 2024 | VRNA | ↓ Sell | 881,960 | $5.01 | $4.4M | Direct | Dec 6, 2024 (0d) |
| Dec 2, 2024 | VRNA | ↓ Sell | 113,240 | $5.01 | $567K | Direct | Dec 2, 2024 (0d) |
| Nov 26, 2024 | VRNA | ↓ Sell | 2,400 | $5.00 | $12K | Direct | Nov 26, 2024 (0d) |
| Nov 11, 2024 | VRNA | ↓ Sell | 2,400 | $5.00 | $12K | Direct | Nov 13, 2024 (2d) |
| Nov 4, 2024 | VRNA | ↓ Sell | 129,672 | $4.38 | $568K | Direct | Nov 5, 2024 (1d) |
| Oct 25, 2024 | VRNA | ↓ Sell | 144,560 | $4.38 | $633K | Direct | Oct 25, 2024 (0d) |
| Oct 22, 2024 | VRNA | ↓ Sell | 525,768 | $4.38 | $2.3M | Direct | Oct 22, 2024 (0d) |
| Sep 11, 2024 | VRNA | ↓ Sell | 600,000 | $3.76 | $2.3M | Direct | Sep 13, 2024 (2d) |
| Aug 13, 2024 | VRNA | ↓ Sell | 400,000 | $3.20 | $1.3M | Direct | Aug 14, 2024 (1d) |
| Aug 7, 2023 | VRNA | ↓ Sell | 275,888 | $2.52 | $694K | Direct | Aug 7, 2023 (0d) |
| Aug 2, 2023 | VRNA | ↓ Sell | 179,648 | $2.64 | $475K | Direct | Aug 3, 2023 (1d) |
| May 1, 2023 | VRNA | ↓ Sell | 455,528 | $2.58 | $1.2M | Direct | May 3, 2023 (2d) |
| Feb 1, 2023 | VRNA | ↓ Sell | 413,168 | $2.56 | $1.1M | Direct | Feb 3, 2023 (2d) |
| Dec 20, 2022 | VRNA | ↓ Sell | 600,000 | $2.12 | $1.3M | Direct | Dec 21, 2022 (1d) |
| Nov 1, 2022 | VRNA | ↓ Sell | 13,160 | $1.67 | $22K | Direct | Nov 3, 2022 (2d) |
| Aug 9, 2022 | VRNA | ↓ Sell | 600,000 | $1.75 | $1.1M | Direct | Aug 11, 2022 (2d) |
| Aug 1, 2022 | VRNA | ↓ Sell | 13,168 | $0.70 | $9K | Direct | Aug 3, 2022 (2d) |
| May 3, 2022 | VRNA | ↓ Sell | 12,512 | $0.50 | $6K | Direct | May 5, 2022 (2d) |
| Feb 2, 2022 | VRNA | ↓ Sell | 10,416 | $0.76 | $8K | Direct | Feb 3, 2022 (1d) |
| Nov 2, 2021 | VRNA | ↓ Sell | 10,416 | $0.65 | $7K | Direct | Nov 3, 2021 (1d) |
| Aug 2, 2021 | VRNA | ↓ Sell | 10,416 | $0.77 | $8K | Direct | Aug 3, 2021 (1d) |
| May 3, 2021 | VRNA | ↓ Sell | 10,416 | $0.87 | $9K | Direct | May 5, 2021 (2d) |
| Mar 1, 2021 | VRNA | ↓ Sell | 26,728 | $1.14 | $31K | Direct | Mar 3, 2021 (2d) |
| Sep 30, 2019 | DOVA | ↓ Sell | 775 | $28.00 | $22K | Direct | Oct 2, 2019 (2d) |
| Jul 1, 2019 | DOVA | ↓ Sell | 1,545 | $14.17 | $22K | Direct | Jul 2, 2019 (1d) |
| Dec 19, 2018 | DOVA | ↑ Buy | 2,500 | $6.28 | $16K | Direct | Dec 21, 2018 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark W Hahn's insider trades
Mark W Hahn is Chief Financial Officer at Verona Pharma (VRNA). Since Dec 19, 2018, Mark has reported 1 open-market purchase worth $16K and 30 sales worth $35.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (22 filings), shares withheld for taxes (15 filings), option exercises (5 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.